Immune Resolution After Staphylococcus Aureus Bacteremia



Status:Recruiting
Conditions:Infectious Disease, Hospital
Therapuetic Areas:Immunology / Infectious Diseases, Other
Healthy:No
Age Range:18 - Any
Updated:7/14/2018
Start Date:June 2013
End Date:December 2019

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

The purpose of this study is to determine how monocyte HLA-DR and other markers of immune
function change with time in patients with and without prior immune dysfunction who survive
sepsis from Staphylococcus aureus bacteremia.

We hypothesize that patients with prior immune dysfunction will have greater reductions in
HLA-DR and other markers of immune function after an episode of sepsis than people who do not
have prior immune dysfunction.


Inclusion Criteria:

- At least one blood culture positive for S. aureus

- Patients aged ≥18 years

- At least two of four systemic inflammatory response syndrome (SIRS) criteria on the
day of positive blood cultures. SIRS criteria are:

- Body temperature less than 36°C(96.8°F) or greater than 38°C(100.4°F)

- Heart rate greater than 90 beats per minute

- Tachypnea (high respiratory rate), with greater than 20 breaths per minute; or,
an arterial partial pressure of carbon dioxide less than 32 mmHg

- WBC less than 4000 cells/mm³ (4 x 109 cells/L) or greater than 12,000 cells/mm³
(12 x 109 cells/L); or the presence of greater than 10% immature neutrophils
(band forms)

Exclusion Criteria:

- Sequential Organ Failure Assessment (SOFA) score > 12 on day of positive blood
cultures

- Survival expected to be < 7 days from positive blood cultures
We found this trial at
1
site
University of Chicago Hospital
Chicago, Illinois 60637
Phone: 773-702-3804
?
mi
from
Chicago, IL
Click here to add this to my saved trials